Does lung cancer screening with low-dose computerized tomography improve survival?

Area of Science:

• Thoracic Surgery
• Pulmonary Medicine
• Diagnostic Imaging

Background:

• Lung cancer remains a leading cause of cancer-related mortality worldwide.
• Early detection is crucial for improving patient survival rates.
• Current screening methods require evaluation for efficacy and safety.

Purpose of the Study:

• To determine if lung cancer screening using low-dose computed tomography (LDCT) improves survival.
• To synthesize the best available evidence on LDCT lung cancer screening.
• To compare LDCT screening outcomes against usual care and chest X-ray screening.

Main Methods:

• Systematic review of literature following a structured protocol.
• Inclusion of 8 randomized control trials and 1 meta-analysis representing best evidence.
• Tabulation of study characteristics, outcomes, and results for comparative analysis.

Main Results:

• LDCT screening populations showed a higher incidence of early lung cancer detection.
• Key trials (NELSON, NLST) demonstrated significant survival benefits, reducing lung cancer-specific mortality by over 20%.
• Potential harms include complications from diagnostic procedures and costs associated with overdiagnosis.

Conclusions:

• Lung cancer screening with LDCT leads to earlier detection of low-stage cancers in high-risk individuals.
• LDCT screening offers improved survival compared to usual clinical care or chest X-ray.
• The benefits of LDCT screening must be weighed against potential harms and costs.